Wallroth Donald E. 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009
Insider Transaction Report
Form 4
Wallroth Donald E.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+30,000→ 30,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (30,000 underlying) - Award
Employee Stock Option (right to buy)
2009-05-12+60,000→ 60,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]This option vests and becomes exercisable in two equal annual installments of 15,000 shares each, beginning on May 12, 2010.
- [F2]This option vests and becomes exercisable in four equal annual installments of 15,000 shares each, beginning on May 12, 2010.